Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.

Wolfson JA, Richman JS, Sun CL, Landier W, Leung K, Smith EP, O'Donnell M, Bhatia S.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1133-1141. doi: 10.1158/1055-9965.EPI-18-0430. Epub 2018 Sep 27.

2.

Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.

Wolfson J, Sun CL, Wyatt L, Stock W, Bhatia S.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):312-320. doi: 10.1158/1055-9965.EPI-16-0722. Epub 2017 Feb 16.

3.

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.

Kahn JM, Keegan TH, Tao L, Abrahão R, Bleyer A, Viny AD.

Cancer. 2016 Sep 1;122(17):2723-30. doi: 10.1002/cncr.30089. Epub 2016 Jun 10.

4.

Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.

Ko RH, Ji L, Barnette P, Bostrom B, Hutchinson R, Raetz E, Seibel NL, Twist CJ, Eckroth E, Sposto R, Gaynon PS, Loh ML.

J Clin Oncol. 2010 Feb 1;28(4):648-54. doi: 10.1200/JCO.2009.22.2950. Epub 2009 Oct 19.

5.

Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

Burke MJ, Gossai N, Wagner JE, Smith AR, Bachanova V, Cao Q, MacMillan ML, Stefanski HS, Weisdorf DJ, Verneris MR.

Biol Blood Marrow Transplant. 2013 Jan;19(1):138-42. doi: 10.1016/j.bbmt.2012.08.020. Epub 2012 Sep 6.

6.

Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland.

Jatczak-Gaca A, Styczynski J, Koltan A, Debski R, Pogorzala M, Wysocki M.

Leuk Lymphoma. 2015 Jul;56(7):2212-4. doi: 10.3109/10428194.2014.999325. Epub 2015 Feb 9. No abstract available.

PMID:
25547656
7.

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.

Oriol A, Vives S, Hernández-Rivas JM, Tormo M, Heras I, Rivas C, Bethencourt C, Moscardó F, Bueno J, Grande C, del Potro E, Guardia R, Brunet S, Bergua J, Bernal T, Moreno MJ, Calvo C, Bastida P, Feliu E, Ribera JM; Programa Español de Tratamiento en Hematologia Group.

Haematologica. 2010 Apr;95(4):589-96. doi: 10.3324/haematol.2009.014274. Epub 2010 Feb 9.

8.

Association of clinical trial enrollment and survival using contemporary therapy for pediatric acute lymphoblastic leukemia.

Moke DJ, Oberley MJ, Bhojwani D, Parekh C, Orgel E.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26788. Epub 2017 Sep 6.

PMID:
28876513
9.

Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.

Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.

J Clin Oncol. 2005 Nov 1;23(31):7942-50. Erratum in: J Clin Oncol. 2008 May 1;26(13):2238.

PMID:
16258094
10.

A comparison of clinical trial enrollment between adolescent and young adult (AYA) oncology patients treated at affiliated adult and pediatric oncology centers.

Downs-Canner S, Shaw PH.

J Pediatr Hematol Oncol. 2009 Dec;31(12):927-9. doi: 10.1097/MPH.0b013e3181b91180.

PMID:
19855302
11.

Acute lymphoblastic leukemia in adolescents and young adults.

Ribera JM, Oriol A.

Hematol Oncol Clin North Am. 2009 Oct;23(5):1033-42, vi. doi: 10.1016/j.hoc.2009.07.002. Review.

PMID:
19825451
12.

Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.

Junghanns AS, Wittig S, Woehlecke C, Lehmann T, Arndt C, Gruhn B.

J Cancer Res Clin Oncol. 2015 Dec;141(12):2221-8. doi: 10.1007/s00432-015-2018-y. Epub 2015 Jul 30.

PMID:
26224397
13.

Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.

Navarrete M, Rossi E, Brivio E, Carrillo JM, Bonilla M, Vasquez R, Peña A, Fu L, Martinez R, Espinoza CM, Lacayo LF, Rodriguez H, Batista R, Barr R, Howard SC, Ribeiro RC, Masera G, Biondi A, Conter V, Valsecchi MG.

Pediatr Blood Cancer. 2014 May;61(5):803-9. doi: 10.1002/pbc.24911. Epub 2013 Dec 24.

PMID:
24376115
14.

High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.

Kozlowski P, Åström M, Ahlberg L, Bernell P, Hulegårdh E, Hägglund H, Karlsson K, Markuszewska-Kuczymska A, Tomaszewska-Toporska B, Smedmyr B, Hallböök H.

Haematologica. 2012 Sep;97(9):1414-21. doi: 10.3324/haematol.2011.057851. Epub 2012 Apr 17.

15.

Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia.

Chen H, Liu KY, Xu LP, Liu DH, Chen YH, Zhao XY, Han W, Zhang XH, Wang Y, Zhang YY, Qin YZ, Liu YR, Huang XJ.

J Hematol Oncol. 2012 Jun 8;5:29. doi: 10.1186/1756-8722-5-29.

16.

DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.

Nielsen SN, Grell K, Nersting J, Abrahamsson J, Lund B, Kanerva J, Jónsson ÓG, Vaitkeviciene G, Pruunsild K, Hjalgrim LL, Schmiegelow K.

Lancet Oncol. 2017 Apr;18(4):515-524. doi: 10.1016/S1470-2045(17)30154-7. Epub 2017 Mar 1.

PMID:
28258828
17.

Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia.

Orellana-Noia VM, Douvas MG.

Curr Hematol Malig Rep. 2018 Apr;13(2):100-108. doi: 10.1007/s11899-018-0442-1. Review.

PMID:
29442287
18.

The effect of central nervous system involvement and irradiation in childhood acute lymphoblastic leukemia: Lessons from the NOPHO ALL-92 and ALL-2000 protocols.

Taskinen M, Oskarsson T, Levinsen M, Bottai M, Hellebostad M, Jonsson OG, Lähteenmäki P, Schmiegelow K, Heyman M.

Pediatr Blood Cancer. 2017 Feb;64(2):242-249. doi: 10.1002/pbc.26191. Epub 2016 Oct 17.

PMID:
27748030
19.

Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.

Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G, Schmitt C, Lejars O, Schneider P, Demeocq F, Bader-Meunier B, Bernaudin F, Perel Y, Auclerc MF, Cayuela JM, Leverger G, Baruchel A; FRALLE Group.

Haematologica. 2012 Nov;97(11):1743-50. doi: 10.3324/haematol.2011.059584. Epub 2012 May 11.

20.

Improved clinical trial enrollment in adolescent and young adult (AYA) oncology patients after the establishment of an AYA oncology program uniting pediatric and medical oncology divisions.

Shaw PH, Boyiadzis M, Tawbi H, Welsh A, Kemerer A, Davidson NE, Ritchey AK.

Cancer. 2012 Jul 15;118(14):3614-7. doi: 10.1002/cncr.26634. Epub 2011 Dec 27.

Supplemental Content

Support Center